Euroglyphus maynei, IgE, Serum
Use
Establishing a diagnosis of an allergy to Euroglyphus maynei. It helps in defining the allergen responsible for eliciting signs and symptoms and identifying allergens responsible for allergic response and/or anaphylactic episode. It is used to confirm sensitization prior to beginning immunotherapy and to investigate the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.
Special Instructions
Testing for IgE antibodies is not useful in patients who have been previously treated with immunotherapy to determine if residual clinical sensitivity exists, or in cases where medical management does not depend upon identification of allergen specificity.
Limitations
False-positive results for IgE antibodies may occur in patients with markedly elevated serum IgE (>2500 kU/L) due to nonspecific binding to allergen solid phases. Also, some individuals with clinically insignificant sensitivity to allergens may have measurable levels of IgE antibodies in serum, and test results must be interpreted in the clinical context.
FDA ApprovedNew York Approved
Methodology
Immunoassay (FEIA)
Biomarkers
LOINC Codes
- 6114-3
- 6114-3
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL for every 5 allergens requested
Minimum Volume
For 1 allergen: 0.3 mL
Container
Preferred: Serum gel; Acceptable: Red top
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Storage Instructions
Refrigerated (preferred) - 14 days, Frozen - 90 days
Causes for Rejection
Gross hemolysis OK, Gross lipemia OK
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |